US › Healthcare

Palatin Technologies, Inc. Common Stock (PTN)

US · Healthcare · Biotechnology

$8.01-2.67%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$3.9M
Net profit
$-1.4M
Profit YoY
+70.2%
EPS
$-0.37
EPS estimate
$-0.82
Net margin
-36.5%

EPS came in at -0.37 against a street estimate of -0.82 — a beat of 54.9%.

Key statistics

Market cap
$13.7M
P/E
70.0
Forward P/E
42.9
P/B
1.29
Book value
$5.96
EPS (TTM)
$0.11
52-week high
$31.00
52-week low
$5.00
50-day MA
$11.30
200-day MA
$15.76
Beta
-0.07

Analyst view

Analysts rate Palatin Technologies, Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $53.50.

Shareholding

Insiders
7.86%
Institutions
55.72%

Largest institutional holders

FundStake
Driehaus Capital Management LLC9.37%
HHG PLC7.87%
Logos Global Management LP7.87%
RA Capital Management, LLC3.93%
Perceptive Advisors LLC3.48%
Balyasny Asset Management LLC2.31%
SUPERSTRING CAPITAL MANAGEMENT LP2.02%
Morgan Stanley - Brokerage Accounts1.53%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Palatin Technologies, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.